Asprosin: A systemic fasting-induced adipokine with widespread physiological effects and therapeutic potential

Asprosin, a fasting-induced adipokine derived from the C-terminal cleavage of profibrillin-1, modulates glucose homeostasis and appetite and participates in multiple physiological and pathophysiological processes. White adipose tissue is the main source of circulating asprosin, although pancreatic beta (β)-cells, salivary glands, and cartilage also produce it. Asprosin stimulates hepatic glucose release via olfactory receptor (OLFR734)-dependent G protein–cAMP–PKA signaling and promotes feeding by activating hypothalamic Agouti-related peptide (AgRP) neurons; dysregulated asprosin levels associate with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and reproductive and cardiovascular disorders. This narrative review summarizes the discovery, sources, signaling mechanisms, systemic effects (endocrine/metabolic, gastrointestinal, nervous, cardiovascular, respiratory, reproductive, renal, musculoskeletal), and therapeutic implications of asprosin, and highlights areas where further research is needed.

Authors

Institutions

Publication Details

Journal
Biochemistry and Biophysics Reports
Published
2026-11-18
DOI
https://doi.org/10.1016/j.bbrep.2026.102884
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Asprosin: A systemic fasting-induced adipokine with widespread physiological effects and therapeutic potential

Mihret Getnet, Hailu Aragie, Lemlemu Maru, Hadush Tinsiae Kahsay et al.
Biochemistry and Biophysics Reports
Adipokines, Inflammation, and Metabolic Diseases
article

Asprosin: A systemic fasting-induced adipokine with widespread physiological effects and therapeutic potential

Mihret Getnet, Hailu Aragie, Lemlemu Maru, Hadush Tinsiae Kahsay, Mitku Mamo Tadergew
article en

Abstract

Asprosin, a fasting-induced adipokine derived from the C-terminal cleavage of profibrillin-1, modulates glucose homeostasis and appetite and participates in multiple physiological and pathophysiological processes. White adipose tissue is the main source of circulating asprosin, although pancreatic beta (β)-cells, salivary glands, and cartilage also produce it. Asprosin stimulates hepatic glucose release via olfactory receptor (OLFR734)-dependent G protein–cAMP–PKA signaling and promotes feeding by activating hypothalamic Agouti-related peptide (AgRP) neurons; dysregulated asprosin levels associate with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and reproductive and cardiovascular disorders. This narrative review summarizes the discovery, sources, signaling mechanisms, systemic effects (endocrine/metabolic, gastrointestinal, nervous, cardiovascular, respiratory, reproductive, renal, musculoskeletal), and therapeutic implications of asprosin, and highlights areas where further research is needed.

Biochemistry and Biophysics ReportsVol. 48
Aksum University (ET), University of Gondar (ET)
Good health and well-being
Adipokines, Inflammation, and Metabolic Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon